DAP3 and hepatocellular carcinoma: Mechanistically, DTYMK, DAP3, and STMN1, which were targeted by hsa-miR-1343-3p, weresignificantly downregulated in HCC cells when hsa_circ_0002003 was silenced andwere significantly correlated with poor prognosis in patients with HCC.